Senolytic drugs: from discovery to translation

Medicine and Dentistry

• Clinical Trial 100%
• Programmed Cell Death 100%
• Frailty 100%
• Eye Disease 100%
• Diseases 100%
• Cardiovascular Disease 50%
• Cancer Therapy 50%
• Diabetes 50%
• Alzheimer's Disease 50%
• Silo-Filler's Disease 50%
• Cancer 50%
• Bone Marrow Transplantation 50%
• Sulfhemoglobinemia 50%
• Water-Electrolyte Imbalance 50%
• Upregulation 50%
• Osteoporosis 50%
• Liver Disease 50%
• Antiapoptotic 50%
• Nephropathy 50%
• Idiopathic Pulmonary Fibrosis 50%
• Organ Transplantation 50%
• Childhood Cancer 50%
• Osteoarthritis 50%
• Multiple Chronic Conditions 50%
• Dasatinib 50%
• COVID-19 50%
• Morbidity 50%
• Quercetin 50%
• Fisetin 50%
• Musculoskeletal Disease 50%
• Dermatosis 50%
• Inflammation 50%
• Navitoclax 50%
• Health Expenditure 50%
• Proteans 50%
• Neurodevelopmental Disorder 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Clinical Trial 100%
• Frailty 100%
• Eye Disease 100%
• Diseases 100%
• Malignant Neoplasm 50%
• Inflammation 50%
• Liver Disease 50%
• Hematologic Disease 50%
• Antiapoptotic 50%
• Kidney Disease 50%
• Lung Disease 50%
• Preclinical Study 50%
• Childhood Cancer 50%
• Osteoarthritis 50%
• Multiple Chronic Conditions 50%
• Fibrosing Alveolitis 50%
• Dasatinib 50%
• Alzheimer's Disease 50%
• Morbidity 50%
• Quercetin 50%
• Skin Disease 50%
• Musculoskeletal Disease 50%
• Navitoclax 50%
• Fisetin 50%
• Cardiovascular Disease 50%
• Metabolic Disorder 50%
• Mental Diseases 50%

Keyphrases

• Senolytics 100%
• Senescent Cells 77%
• Clinical Trials 22%
• Senescence-associated Secretory Phenotype 22%
• Apoptosis 22%
• Frailty 22%
• Radiation Therapy 11%
• Diabetes 11%
• Alzheimer's Disease 11%
• Age-related 11%
• Aging 11%
• Inflammation 11%
• Bone Marrow Transplantation 11%
• Hematological Diseases 11%
• Cancer Treatment 11%
• Aging Mechanism 11%
• Osteoporosis 11%
• Liver Disease 11%
• Drug Class 11%
• Lung Disorders 11%
• Kidney Disease 11%
• Over 40 11%
• Hypothesis-driven Approach 11%
• Eye Diseases 11%
• Organ Transplantation 11%
• Skin Diseases 11%
• Osteoarthritis 11%
• Multiple Chronic Conditions 11%
• Idiopathic Pulmonary Fibrosis 11%
• Dasatinib 11%
• Neighboring Cells 11%
• COVID-19 11%
• Metabolic Disorders 11%
• Quercetin 11%
• Fisetin 11%
• Musculoskeletal Disorders 11%
• Chronic Disorders 11%
• Skin Problems 11%
• Navitoclax 11%
• Hit-and-run 11%
• Eye Disorders 11%
• Health Expenditure 11%
• Disorder Potential 11%
• Morbimortality 11%
• Alzheime's Disease 11%
• Cardiovascular Disorders 11%
• Liver-kidney 11%
• Anti-apoptotic Pathway 11%
• Multiple Disorders 11%
• Inflammatory Senescence 11%